Hinz Katrin M, Meyer Katja, Kinne Anita, Schülein Ralf, Köhrle Josef, Krause Gerd
Leibniz-Institut für Molekulare Pharmakologie (FMP) (K.M.H., K.M., A.K., R.S., G.K.), 13125 Berlin, Germany; and Institut für Experimentelle Endokrinologie (J.K.), Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Mol Endocrinol. 2015 Jun;29(6):933-42. doi: 10.1210/me.2015-1044. Epub 2015 May 6.
Thyroid hormones (THs) are transported across cell membranes by different transmembrane transporter proteins. In previous studies, we showed marked 3,3'-diiodothyronine (3,3'-T2) but moderate T3 uptake by the L-type amino acid transporter 2 (Lat2). We have now studied the structure-function relationships of this transporter and TH-like molecules. Our Lat2 homology model is based on 2 crystal structures of the homologous 12-transmembrane helix transporters arginine/agmatine antiporter and amino acid/polyamine/organocation transporter. Model-driven mutagenesis of residues lining an extracellular recognition site and a TH-traversing channel identified 9 sensitive residues. Using Xenopus laevis oocytes as expression system, we found that side chain shortening (N51S, N133S, N248S, and Y130A) expanded the channel and increased 3,3'-T2 transport. Side chain enlargements (T140F, Y130R, and I137M) decreased 3,3'-T2 uptake, indicating channel obstructions. The opposite results with mutations maintaining (F242W) or impairing (F242V) uptake suggest that F242 may have a gating function. Competitive inhibition studies of 14 TH-like compounds revealed that recognition by Lat2 requires amino and carboxylic acid groups. The size of the adjacent hydrophobic group is restricted. Bulky substituents in positions 3 and 5 of the tyrosine ring are allowed. The phenolic ring may be enlarged, provided that the whole molecule is flexible enough to fit into the distinctly shaped TH-traversing channel of Lat2. Taken together, the next Lat2 features were identified 1) TH recognition site; 2) TH-traversing channel in the center of Lat2; and 3) switch site that potentially facilitates intracellular substrate release. Together with identified substrate features, these data help to elucidate the molecular mechanisms and role of Lat2 in T2 transport.
甲状腺激素(THs)通过不同的跨膜转运蛋白穿过细胞膜。在先前的研究中,我们发现L型氨基酸转运体2(Lat2)对3,3'-二碘甲腺原氨酸(3,3'-T2)有显著摄取,但对T3的摄取适中。我们现在研究了这种转运体与类甲状腺激素分子的结构-功能关系。我们的Lat2同源模型基于同源的12跨膜螺旋转运体精氨酸/胍丁胺反向转运体和氨基酸/多胺/有机阳离子转运体的2个晶体结构。对位于细胞外识别位点和TH穿越通道的残基进行模型驱动的诱变,确定了9个敏感残基。使用非洲爪蟾卵母细胞作为表达系统,我们发现侧链缩短(N51S、N133S、N248S和Y130A)会扩大通道并增加3,3'-T2的转运。侧链增大(T140F、Y130R和I137M)会减少3,3'-T2的摄取,表明通道受阻。维持(F242W)或损害(F242V)摄取的突变产生相反结果,表明F242可能具有门控功能。对14种类甲状腺激素化合物的竞争性抑制研究表明,Lat2的识别需要氨基和羧基。相邻疏水基团的大小受到限制。酪氨酸环的3位和5位允许有庞大的取代基。只要整个分子足够灵活以适应Lat2独特形状的TH穿越通道,酚环可以扩大。综上所述,确定了Lat2的以下特征:1)TH识别位点;2)Lat2中心的TH穿越通道;3)可能促进细胞内底物释放的开关位点。连同已确定的底物特征,这些数据有助于阐明Lat2在T2转运中的分子机制和作用。